Dave Repp

Dave focuses on the creation of life science start-up companies and business opportunities based on technologies discovered and developed at the University of Michigan.
He has over 15 years of experience in research commercialization, new venture creation, and business consulting in the life sciences and high tech industries.
Before joining the Ventures team, Dave was President and COO of Gema Diagnostics, a venture-backed molecular diagnostics company seeking to improve clinical outcomes in in vitro fertilization.
Prior to Gema, he helped launch and was Vice President of University of Michigan spin-out, Avidimer Therapeutics.
He consulted at ANGLE Technology, a venture investment and management consulting firm focused on life sciences and high tech opportunities in the US and UK, and Deloitte Consulting where he was on the Strategic Advisory Team for the firm’s High Tech Industry Practice.
Dave earned his MBA (Samuel Zell Scholar) from the Stephen M.
Ross School of Business at the University of Michigan and BS and MS degrees in Mechanical Engineering from the University of Michigan.